The in vitro effect of S-stage-specific drugs on the fetal hemoglobin (Hb F) potential of erythroid precursors and progenitors was tested by exposing bone marrow cells to 5-aza-2'-deoxycytidine, Ara-C, or hydroxyurea in suspension cultures and reculturing the cells in drug-free clonal cultures. Analysis of Hb F in the erythroblasts present at the end of suspension cultures and in the erythroid colonies formed from treated progenitors showed that 1 X 10(-9)-5 X 10(-8) M 5-aza-2'-deoxycytidine produced a concentration-related increase in the proportion of Hb F-positive erythroblasts, of Hb F-positive erythroid CFU (CFUe) colonies, and at the higher doses used, an increased Hb F expression in erythroid burst-forming unit (BFUe)-derived colonies. Preincubation of bone marrow cells with Ara-C produced significant megaloblastic changes by the end of the 2-d incubation and increased the proportion of Hb F-positive erythroblasts, CFUe colonies, and e-clusters, but BFUe-derived progeny was unaffected. Hydroxyurea failed to produce significant changes in Hb F at the range of concentrations used. The data raise the possibility of more than one mechanism underlying the stimulation of Hb F by S-stage drugs.
R Galanello, G Stamatoyannopoulos, T Papayannopoulou
Title and authors | Publication | Year |
---|---|---|
Salubrinal induces fetal hemoglobin expression via the stress-signaling pathway in human sickle erythroid progenitors and sickle cell disease mice
Lopez NH, Li B, Palani C, Siddaramappa U, Takezaki M, Xu H, Zhi W, Pace BS |
PloS one | 2022 |
FK228 Analogues Induce Fetal Hemoglobin in Human Erythroid Progenitors
L Makala, SD Maro, TF Lou, S Sivanand, JM Ahn, BS Pace |
Anemia | 2012 |
The proinflammatory cytokine GM-CSF downregulates fetal hemoglobin expression by attenuating the cAMP-dependent pathway in sickle cell disease
T Ikuta, AD Adekile, DR Gutsaeva, JB Parkerson, SD Yerigenahally, B Clair, A Kutlar, N Odo, CA Head |
Blood Cells Molecules and Diseases | 2011 |
Enzymatic Methylation of DNA in Cultured Human Cells Studied by Stable Isotope Incorporation and Mass Spectrometry
JL Herring, DK Rogstad, LC Sowers |
Chemical Research in Toxicology | 2009 |
Developmental- and differentiation-specific patterns of human gamma- and beta-globin promoter DNA methylation
R Mabaera, CA Richardson, K Johnson, M Hsu, S Fiering, CH Lowrey |
Blood | 2007 |
Understanding mechanisms of γ-globin gene regulation to develop strategies for pharmacological fetal hemoglobin induction
BS Pace, S Zein |
Developmental Dynamics | 2006 |
Control of globin gene expression during development and erythroid differentiation
G Stamatoyannopoulos |
Experimental Hematology | 2005 |
Pharmacological Induction of Fetal Hemoglobin Synthesis using Histone Deacetylase Inhibitors
H Cao |
Hematology | 2004 |
Mechanism for fetal globin gene expression: role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathway
T Ikuta, S Ausenda, MD Cappellini |
Proceedings of the National Academy of Sciences | 2001 |
Advances in experimental treatment of β-thalassaemia
GP Rodgers, Y Saunthararajah |
Expert Opinion on Investigational Drugs | 2001 |
Mechanism for fetal globin gene expression: Role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathway
T Ikuta, S Ausenda, MD Cappellini |
Proceedings of the National Academy of Sciences | 2001 |
Pharmacologic Induction of Fetal Hemoglobin Synthesis: Cellular and Molecular Mechanisms
YM Yang, B Pace |
Pediatric Pathology & Molecular Medicine | 2001 |
Fetal Erythropoiesis after Allogeneic Bone Marrow Transplantation Estimated by the Peripheral Blood Erythrocytes Containing Hemoglobin F (F-cells)
J Meletis, M Dalekou, M Samarkos, E Paravasiliou, C Meletis, K Konstantopoulos, E Apostolidou, V Komninaka, E Terpos, O Benopoulou, K Korovesis, E Variami, D Loukopoulos |
Hematology | 2001 |
Reduction of the Clinical Severity of Sickle Cell/β-Thalassemia with Hydroxyurea: The Experience of a Single Center in Greece
D Loukopoulos, E Voskaridou, V Kalotychou, M Schina, A Loutradi, I Theodoropoulos |
Blood Cells, Molecules, and Diseases | 2000 |
Butyrate-inducible elements in the human γ-globin promoter
BS Pace, YR Chen, A Thompson, SR Goodman |
Experimental Hematology | 2000 |
Long-term hydroxyurea treatment in young sickle cell patients
M Maier-Redelsperger, D Labie, J Elion |
Current Opinion in Hematology | 1999 |
UNDERSTANDING FETAL GLOBIN GENE EXPRESSION: A STEP TOWARDS EFFECTIVE HbF REACTIVATION IN HAEMOGLOBINOPATHIES
SM Jane, JM Cunningham |
British Journal of Haematology | 1998 |
Alterations in Protein-DNA Interactions in the γ-Globin Gene Promoter in Response to Butyrate Therapy
T Ikuta, YW Kan, PS Swerdlow, DV Faller, SP Perrine |
Blood | 1998 |
A Bioavailability and Pharmacokinetic Study of Oral and Intravenous Hydroxyurea
GI Rodriguez, JG Kuhn, GR Weiss, SG Hilsenbeck, JR Eckardt, A Thurman, DA Rinaldi, S Hodges, DD Hoff, EK Rowinsky |
Blood | 1998 |
Transgenic mouse model of pharmacologic induction of fetal hemoglobin: Studies using a new ribonucleotide reductase inhibitor, didox
BS Pace, HL Elford, G Stamatoyannopoulos |
American Journal of Hematology | 1994 |
Effects of hydroxyurea and cyclic adenosine monophosphate/protein kinase A inhibitors on the expression of the human chorionic gonadotropin alpha subunit and c-myc genes in choriocarcinoma
JL Arbiser, ZK Arbiser, JA Majzoub |
Journal of Endocrinological Investigation | 1993 |
Impact of 5-azacytidine on insulin binding and insulin-induced receptor formation in Tetrahymena
G Csaba, P Kovács |
Biochemical and Biophysical Research Communications | 1990 |